Simplifying Global Compliance
Duchesnay Flagged for Omitting Risks of Morning Sickness Drug
Shortly after Duchesnay received FDA approval for its morning sickness drug Diclegis, the agency says the Canadian drugmaker sent a letter to customers touting the drug’s benefits but none of its risks.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing